<article>
<section>
<h1 id="header">Quantitative assays to measure the transport activity of the mitochondrial calcium uniporter in cell lines or <i>Xenopus</i> oocytes</h1>
<p><time datetime="2021-11-26">Published: November 26, 2021</time></p>
<p>Madison X. Rodriguez,<sup><a href="#aff1">1</a>,<a href="#fn1">2</a></sup> Anna M. Van Keuren,<sup><a href="#aff1">1</a>,<a href="#fn1">2</a></sup> and Ming-Feng Tsai<sup><a href="#aff1">1</a>,<a href="#fn1">2</a>,<a href="#fn2">3</a>,<a href="#fn3">4</a>,<a href="#cor1">*</a></sup></p>
<p id="aff1"><sup>1</sup>Department of Physiology and Biophysics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA</p>
<p id="fn1"><sup>2</sup>These authors contributed equally</p>
<p id="fn2"><sup>3</sup>Technical contact</p>
<p id="fn3"><sup>4</sup>Lead contact</p>
<p id="cor1"><sup>*</sup>Correspondence: <a href="mailto:ming-feng.tsai@cuanschutz.edu">ming-feng.tsai@cuanschutz.edu</a></p>
<p><span class="open-access">Open Access</span> • DOI: <a href="https://doi.org/10.1016/j.xpro.2021.100979">10.1016/j.xpro.2021.100979</a></p>
</section>
<section>
<h2 id="summary">Summary</h2>
<p>The mitochondrial calcium uniporter, which mediates mitochondrial Ca<sup>2+</sup> uptake, regulates key cellular functions, including intracellular Ca<sup>2+</sup> signaling, cell-fate determination, and mitochondrial bioenergetics. Here, we describe two complementary strategies to quantify the uniporter’s transport activity. First, we detail a mitochondrial Ca<sup>2+</sup> radionuclide uptake assay in cultured cell lines. Second, we describe electrophysiological recordings of the uniporter expressed in <i>Xenopus</i> oocytes. These approaches enable a detailed kinetic analysis of the uniporter to link its molecular properties to physiological functions.</p>
<p>For complete details on the use and execution of this protocol, please refer to <a class="external-link" href="https://doi.org/10.1085/jgp.201812015">Tsai and Tsai (2018)</a> and <a class="external-link" href="https://doi.org/10.7554/eLife.41112">Phillips et al. (2019)</a>.</p>




<div class="highlights">
<h3>Highlights</h3>
<ul>
<li>Two quantitative approaches to analyze mitochondrial calcium uptake</li>
<li>Measuring mitochondrial calcium uptake in cell lines using calcium-45 radioisotope</li>
<li>Electrical recordings of the mitochondrial calcium uniporter in <i>Xenopus</i> oocytes</li>
</ul>
</div>
<div class="graphical-abstract">
<h3>Graphical abstract</h3>
<figure><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1198-GA.jpg" alt="GraphicalAbstract.jpg"></figure>
</div></section>
<section>
<h2 id="before-you-begin">Before you begin</h2>
<p>The mitochondrial Ca<sup>2+</sup> uniporter is a multi-subunit Ca<sup>2+</sup> channel complex that transports cytoplasmic Ca<sup>2+</sup> into the mitochondrial matrix (<a href="#bib4">Kamer and Mootha, 2015</a>; <a href="#bib9">Rizzuto et al., 2012</a>). Half a century of studies have strongly advanced our knowledge about the uniporter’s molecular mechanisms and pathophysiological roles. However, many critical mechanistic problems still remain poorly understood, such as the molecular basis of the uniporter’s Ca<sup>2+</sup> selectivity, inward rectification of Ca<sup>2+</sup> currents, voltage-dependent gating, etc. There are two established methods to study the uniporter’s transport properties: first, using Ca<sup>2+</sup> sensors to detect mitochondrial Ca<sup>2+</sup> uptake; and second, mitoplast patch-clamp. The former is easy to perform but qualitative in nature (might be semi-quantitative with careful calibration). The latter is quantitative, but the technical barrier is high, so only a few labs worldwide have been able to obtain data using this method. Below we describe two approaches that are highly quantitative but with a much lower technical difficulty compared with mitoplast patch-clamp. We anticipate that adopting these methods would strongly facilitate mechanistic studies of the physiologically crucial uniporter transport process. A comparison of methods to study the uniporter’s Ca<sup>2+</sup> transport is provided below (<a href="#tbl1">Table 1</a>):</p>
<table id="tbl1">
<caption>Table 1. A comparison of methods to study the mitochondrial calcium uniporter</caption>
<thead>
<tr>
<th>Methods</th>
<th>Measuring mitochondrial Ca<sup>2+</sup> uptake using Ca<sup>2+</sup> indicators</th>
<th>Mitoplast patch-clamp</th>
<th>Mitochondrial <sup>45</sup>Ca<sup>2+</sup> uptake (1<sup>st</sup> section below)</th>
<th>Electrophysiological recordings using <i>Xenopus</i> oocytes (2<sup>nd</sup> section below).</th>
</tr>
</thead>
<tbody>
<tr>
<td>Quantitative/qualitative</td>
<td>Qualitative to semi-quantitative</td>
<td>Quantitative</td>
<td>Quantitative</td>
<td>Quantitative</td>
</tr>
<tr>
<td>Difficulty</td>
<td>Low</td>
<td>Very high</td>
<td>Medium</td>
<td>Medium to high</td>
</tr>
<tr>
<td>Advantages</td>
<td>Quick and easy. Excellent for “yes-or-no” questions.</td>
<td>The use of voltage clamp enables accurate control of the driving force for Ca<sup>2+</sup> flux.</td>
<td>The only quantitative method to measure the transport of physiological levels of Ca<sup>2+</sup> (0.1–10 μM)</td>
<td>All advantages of mitoplast patch-clamp, but much easier to do.</td>
</tr>
<tr>
<td>Limitations</td>
<td>Not suitable for absolute quantification.</td>
<td>Years of experience are required to do this properly. Very low throughput.</td>
<td>Institutional support is needed to properly handle <sup>45</sup>Ca<sup>2+</sup> waste.</td>
<td>Regulatory MICU subunits of the uniporter are absent.</td>
</tr>
<tr>
<td>Suggested references</td>
<td>(<a href="#bib10">Rizzuto et al., 1992</a>; <a href="#bib11">Sancak et al., 2013</a>; <a href="#bib13">Tsai et al., 2016</a>)</td>
<td>(<a href="#bib3">Garg and Kirichok, 2019</a>; <a href="#bib5">Kirichok et al., 2004</a>)</td>
<td>(<a href="#bib2">Csordas et al., 2013</a>; <a href="#bib7">Phillips et al., 2019</a>)</td>
<td>(<a href="#bib12">Tsai and Tsai, 2018</a>; <a href="#bib14">Van Keuren et al., 2020</a>)</td>
</tr>
</tbody>
</table>
</section>
<section>
<h2 id="key-resources-table">Key resources table</h2>
<table id="krt">
<thead>
<tr>
<th>REAGENT or RESOURCE</th>
<th>SOURCE</th>
<th>IDENTIFIER</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="3">Biological samples</td>
</tr>
<tr>
<td>
<i>Xenopus laevis</i> frogs</td>
<td>XENOPUS1</td>
<td>#4270</td>
</tr>
<tr>
<td>
<i>Xenopus laevis</i> ovary</td>
<td>XENOPUS1</td>
<td>#10004</td>
</tr>
<tr>
<td colspan="3">Chemicals, peptides, and recombinant proteins</td>
</tr>
<tr>
<td>Lipofectamine 3000</td>
<td>Thermo Fisher Scientific</td>
<td>#L3000015</td>
</tr>
<tr>
<td>Ru360</td>
<td>Synthesized in house (also available from Sigma-Aldrich)</td>
<td>(<a href="#bib15">Ying et al., 1991</a>)(557440-500UG)</td>
</tr>
<tr>
<td>Digitonin</td>
<td>Sigma-Aldrich</td>
<td>D141</td>
</tr>
<tr>
<td>Thapsigargin</td>
<td>Cayman Chemical</td>
<td>10522</td>
</tr>
<tr>
<td>Ca-45 radionuclide</td>
<td>PerkinElmer</td>
<td>NEX013001MC</td>
</tr>
<tr>
<td>Scintillation cocktail</td>
<td>Atlantic Nuclear Corporation</td>
<td>#111175</td>
</tr>
<tr>
<td>Type II collagenase</td>
<td>Worthington Biochemical Corporation</td>
<td>#C6885</td>
</tr>
<tr>
<td>NotI-HF</td>
<td>New England Biolabs</td>
<td>#R3189</td>
</tr>
<tr>
<td>EGTA</td>
<td>Sigma-Aldrich</td>
<td>#03777</td>
</tr>
<tr>
<td colspan="3">Critical commercial assays</td>
</tr>
<tr>
<td>mMESSAGE mMACHINE T3 Transcription kit</td>
<td>Thermo Fisher Scientific</td>
<td>#AM1348</td>
</tr>
<tr>
<td>QIAquick PCR Purification kit</td>
<td>QIAGEN</td>
<td>#28104</td>
</tr>
<tr>
<td>RNeasy MinElute Cleanup kit</td>
<td>QIAGEN</td>
<td>#74204</td>
</tr>
<tr>
<td colspan="3">Experimental models: Cell lines</td>
</tr>
<tr>
<td>HEK 293T</td>
<td>American Type Culture Collection</td>
<td>#CRL-3216</td>
</tr>
<tr>
<td colspan="3">Recombinant DNA</td>
</tr>
<tr>
<td>hME-pOX</td>
<td>Addgene</td>
<td>#178181</td>
</tr>
<tr>
<td colspan="3">Other</td>
</tr>
<tr>
<td>Scintillation vials</td>
<td>Thermo Fisher Scientific</td>
<td>#333715</td>
</tr>
<tr>
<td>Round nitrocellulose membranes</td>
<td>Thermo Fisher Scientific</td>
<td>#097192D</td>
</tr>
<tr>
<td>Vacuum filtration manifold</td>
<td>Merck Millipore</td>
<td>Model 1225</td>
</tr>
<tr>
<td>Scintillation counter</td>
<td>Beckman Coulter</td>
<td>LS 6500</td>
</tr>
<tr>
<td>Oocyte incubator</td>
<td>Revolutionary Science</td>
<td>RS-IF-233</td>
</tr>
<tr>
<td>Pipette puller</td>
<td>SUTTER INSTRUMENT</td>
<td>P-1000</td>
</tr>
<tr>
<td>Microinjector</td>
<td>DRUMMOND SCIENTIFIC COMPANY</td>
<td>Nanoject II</td>
</tr>
<tr>
<td>Air table with Faraday cage</td>
<td>SUTTER INSTRUMENT</td>
<td>AT-3648</td>
</tr>
<tr>
<td>Two electrode voltage clamp station</td>
<td>WARNER INSTRUMENTS</td>
<td>TEV-700</td>
</tr>
<tr>
<td>Patch-clamp amplifier</td>
<td>Molecular Devices</td>
<td>Axopatch 200B</td>
</tr>
<tr>
<td>Digitizer</td>
<td>Molecular Devices</td>
<td>Digidata 1550B</td>
</tr>
<tr>
<td>Inverted microscope</td>
<td>ZEISS</td>
<td>Axiovert 200</td>
</tr>
<tr>
<td>Fast solution change system</td>
<td>WARNER INSTRUMENTSr</td>
<td>SF-77C</td>
</tr>
<tr>
<td>Thermal cycler</td>
<td>Bio-Rad Laboratories</td>
<td>T100</td>
</tr>
<tr>
<td>Fluorometer</td>
<td>HITACHI</td>
<td>F-7100</td>
</tr>
</tbody>
</table>
</section>
<section>
<h2 id="materials-and-equipment">Materials and equipment</h2>
<h3 id="sec2.1">Buffer recipes</h3>
<table id="undtbl1">
<caption>Wash buffer (WB)</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
</tr>
</thead>
<tbody>
<tr>
<td>KCl</td>
<td>120 mM</td>
</tr>
<tr>
<td>MgCl<sub>2</sub>
</td>
<td>1 mM</td>
</tr>
<tr>
<td>EGTA</td>
<td>50 μM</td>
</tr>
<tr>
<td>HEPES, pH 7.2-KOH</td>
<td>25 mM</td>
</tr>
</tbody>
</table>
<p class="table-legend">Store in 4°C for up to a year. Warm up to 25°C before use.</p>
<table id="undtbl2">
<caption>Recording buffer (RB)</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
</tr>
</thead>
<tbody>
<tr>
<td>KCl</td>
<td>120 mM</td>
</tr>
<tr>
<td>MgCl<sub>2</sub>
</td>
<td>1 mM</td>
</tr>
<tr>
<td>EGTA</td>
<td>690 μM</td>
</tr>
<tr>
<td>CaCl2</td>
<td>500 μM</td>
</tr>
<tr>
<td>HEPES, pH 7.0-KOH</td>
<td>25 mM</td>
</tr>
</tbody>
</table>
<p class="table-legend">Store in 4°C for up to a year. Warm up to 25°C before use.</p>
<div class="note">
<span class="note-title">Note:</span> This recipe will produce an RB solution with 300 nM of free [Ca<sup>2+</sup>]. One can adjust EGTA and CaCl<sub>2</sub> concentrations to obtain various levels of free [Ca<sup>2+</sup>]. An online free-Ca<sup>2+</sup> calculator can be found via this link: <a href="https://somapp.ucdmc.ucdavis.edu/pharmacology/bers/maxchelator/CaEGTA-TS.htm">https://somapp.ucdmc.ucdavis.edu/pharmacology/bers/maxchelator/CaEGTA-TS.htm</a>
</div>
<p>We recommend using a Ca<sup>2+</sup> indicator, such as Calcium Green 5N or Fluo-4 to confirm free [Ca<sup>2+</sup>] before flux experiments. In brief, a Ca<sup>2+</sup> indicator can be added to the solution to obtain the fluorescence reading (F) using a fluorometer. Saturating concentrations of Ca<sup>2+</sup> can then be added to obtain the maximal signal, F<sub>max</sub>, followed by adding EGTA to obtain the minimal signal, F<sub>min</sub>. Free Ca<sup>2+</sup> can be calculated using the equation [Ca<sup>2+</sup>] = K<sub>D</sub> ∗ (F – F<sub>min</sub>)/(F<sub>max</sub> – F<sub>min</sub>), where K<sub>D</sub> is the Ca<sup>2+</sup> dissociation constant for the indicators.</p>
<table id="undtbl3">
<caption>ND96</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
</tr>
</thead>
<tbody>
<tr>
<td>KCl</td>
<td>2 mM</td>
</tr>
<tr>
<td>NaCl</td>
<td>96 mM</td>
</tr>
<tr>
<td>CaCl<sub>2</sub>
</td>
<td>1.8 mM</td>
</tr>
<tr>
<td>MgCl<sub>2</sub>
</td>
<td>1 mM</td>
</tr>
<tr>
<td>HEPES, pH 7.4-NaOH</td>
<td>5 mM</td>
</tr>
</tbody>
</table>
<p class="table-legend">Store in 4°C for up to a year. Warm up to 25°C before use.</p>
<table id="undtbl4">
<caption>Digestion buffer (DB)</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
</tr>
</thead>
<tbody>
<tr>
<td>NaCl</td>
<td>96 mM</td>
</tr>
<tr>
<td>KCl</td>
<td>2 mM</td>
</tr>
<tr>
<td>MgCl2</td>
<td>2 mM</td>
</tr>
<tr>
<td>HEPES, pH 7.4- NaOH</td>
<td>5 mM</td>
</tr>
</tbody>
</table>
<p class="table-legend">Store in 4°C for up to a year. Warm up to 25°C before use.</p>
<table id="undtbl5">
<caption>Ca20</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
</tr>
</thead>
<tbody>
<tr>
<td>KCl</td>
<td>2 mM</td>
</tr>
<tr>
<td>NaCl</td>
<td>96 mM</td>
</tr>
<tr>
<td>CaCl<sub>2</sub>
</td>
<td>1.8 mM</td>
</tr>
<tr>
<td>MgCl<sub>2</sub>
</td>
<td>1 mM</td>
</tr>
<tr>
<td>HEPES, pH 7.4-NaOH</td>
<td>5 mM</td>
</tr>
</tbody>
</table>
<p class="table-legend">Store in 4°C for up to a year. Warm up to 25°C before use.</p>
<table id="undtbl6">
<caption>Ca100</caption>
<thead>
<tr>
<th>Reagent</th>
<th>Final concentration</th>
</tr>
</thead>
<tbody>
<tr>
<td>CaCl<sub>2</sub>
</td>
<td>100mM</td>
</tr>
<tr>
<td>HEPES, pH 7.6-NaOH</td>
<td>20 mM</td>
</tr>
</tbody>
</table>
<p class="table-legend">Store in 4°C for up to a year. Warm up to 25°C before use.</p>
</section>
<section>
<h2 id="step-by-step-method-details">Step-by-step method details</h2>
<h3 id="sec3.1">Mitochondrial <sup>45</sup>Ca<sup>2+</sup> uptake assay—Preparing cells</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 1 h, 2–3 days prior to the experiment day</div>
<p>These steps prepare cells for the <sup>45</sup>Ca<sup>2+</sup> uptake assay. The protocol below calls for the use of HEK293T cells, but the same procedure can be readily applied to other types of cells, such as HeLa or CHO cells.</p>
<ol>
<li>If transfection is needed, seed HEK293T cells at 25% density (∼1 × 10<sup>6</sup> cells/well) in 4 wells of a 6-well plate 3 days before the experiment, and transfect the cells the following day using Lipofectamine 3000 according to the manufacturer’s manual.</li>
<li>If transfection is not needed, seed HEK293T cells at 25% density in 4 wells of a 6-well plate 2 days before the flux experiment.</li>
</ol>
<h3 id="sec3.2">Mitochondrial <sup>45</sup>Ca<sup>2+</sup> uptake assay—Performing the assay</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 3 h</div>
<p>The steps below describe the detailed procedures to perform the mitochondrial <sup>45</sup>Ca<sup>2+</sup> uptake assay.</p>
<ol start="3">
<li>Fill 12 scintillation vials with 5 mL of WB, and place these vials on ice to keep them cold.</li>
<li>Set up the vacuum filtration manifold using 0.45 μm pore size round nitrocellulose membranes. Connect the manifold to a vacuum outlet or a vacuum pump. Pass 5 mL of water through each membrane to confirm vacuum power and to wet the membrane.</li>
<li>Prepare 1000× digitonin (30 mM in water) and 500× thapsigargin (2.5 mM in DMSO) stock.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> Digitonin stock solution must be freshly prepared right before the experiment. Thapsigargin stock can be stored in 4°C for up to a month.</div>
<ol start="6">
<li>Add 0.6 μL of concentrated <sup>45</sup>Ca<sup>2+</sup> stock (specific activity: 15–30 mCi/mg) to 0.6 mL of RB. Also, add 30-μM digitonin (to permeabilize cells) and 5-μM thapsigargin (to block the endoplasmic reticulum Ca<sup>2+</sup>-ATPase pump).</li>
<li>Split the solution into 2 microcentrifuge tubes. Add 100 nM Ru360 (a potent uniporter inhibitor) to one of the two tubes, labeled as tube A (no Ru360) and tube B (with Ru360).</li>
<li>Trypsinize HEK293T cells in 2 wells of a 6-well plate. Resuspend the cells in 2–4 mL of DMEM (with 10% FBS), and then count cells using a hemocytometer or an automatic cell counter.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> It is important to apply adequate trypsinization to break large cell clumps, or cell counting would be inaccurate.</div>
<ol start="9">
<li>Transfer 4 × 10<sup>6</sup> cells to a microcentrifuge tube, spin down at 2000 g for 1 min, resuspend the cell in 1 mL of WB, and then spin down again at 2000 g for 1 min.</li>
<li>Discard the supernatant and resuspend the cells in 200 μL of WB, supplemented with 30-μM digitonin and 5-μM thapsigargin. Allow the cells to be permeabilized for at least 2 min before proceeding to step 11.</li>
<li>Add 100 μL of the cell suspension to tube A and mix well to start mitochondrial <sup>45</sup>Ca<sup>2+</sup> uptake. 1 min later, add 100 μL of the remaining cell suspension to tube B to start <sup>45</sup>Ca<sup>2+</sup> uptake in this tube.</li>
<li>2 min, 4 min, and 6 min after <sup>45</sup>Ca<sup>2+</sup> uptake started, transfer 100 μL of each sample into the respective scintillation vials with ice-cold WB. Immediately filter the mix through the vacuum manifold.</li>
<li>Once the solution is filtered through, immediately filter through 5 mL of WB to remove any remaining extramitochondrial <sup>45</sup>Ca<sup>2+</sup>. 6 membranes would be used in steps 6–13 (3-time points for both tubes A and B).</li>
<li>Transfer the membranes into empty scintillation vials and add 15 mL scintillation cocktail for counting. Also, transfer 10 μL of remaining solutions from tube A and tube B into different scintillation vials and add 15-mL scintillation cocktail for counting.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> Shake those scintillation vials with membranes vigorously for at least 30 s to fully extract <sup>45</sup>Ca<sup>2+</sup> into the scintillation cocktail.</div>
<ol start="15">
<li>Repeat steps 6–14 for technical replicates. There should be two membranes for each time point for both tubes A and B.</li>
<li>Measure the counts (CPM) in each vial using a scintillation counter.</li>
<li>Calculate the average of the two readings for each time point to generate a single data point. Multiply the signal from 10 μL of the remaining solution by 10 to obtain the total signal in 100 μL solution.</li>
<li>Follow the instructions in the Expected Outcomes section below to analyze the data.</li>
</ol>
<h3 id="sec3.3">Electrical recordings using <i>Xenopus</i> oocytes—Preparing cRNA</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 10 h</div>
<p>These steps provide instructions about how to prepare cRNA to express the uniporter’s transmembrane subunits in <i>Xenopus</i> oocytes.</p>
<ol start="19">
<li>Linearize 10 μg of a pOX vector containing a human MCU-EMRE (hME, Addgene 178181) fusion construct (MCU and EMRE form the uniporter’s transmembrane region) using 20 U of the NotI-HF restriction enzyme.</li>
<li>Digest hME-pOX for 6 h at 37°C, followed by heat inactivation for 20 min at 65°C using a thermal cycler.</li>
</ol>
<div class="pause-point">
<span class="pause-point-title">Pause point:</span> The DNA can be left in the thermal cycler at 4°C, with the next steps performed in the following day.</div>
<ol start="21">
<li>Confirm complete linearization of the hME vector by running the sample on a 1% DNA gel. A fully linearized sample should run as a single band, as opposed to linearized samples, which show a smear due to DNA supercoiling (<a href="#fig1">Figure 1</a>).
<figure id="fig1"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1198-Fig1.jpg" alt="Fig1.jpg">
<figcaption>
<div class="figcaption-title">Figure 1. Linearization of hME-pOX</div>
<p>The middle lane is nonlinearized sample, while the right lane shows fully linearized DNA.</p>
</figcaption>
</figure>
</li>
<li>Use a Qiagen PCR purification kit to purify linearized DNA according to manufacturer’s instructions.</li>
<li>Use a mMessage mMachine T3 transcription kit to produce cRNA following the manufacturer’s instructions, with 1 μg of linearized DNA used as the template.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> After cRNA synthesis, make sure to digest the DNA template using the Turbo DNase provided with the T3 transcription kit.</div>
<ol start="24">
<li>Purify the cRNA using the Qiagen RNeasy MinElute kit according to the manufacturer’s protocols. and elute with 20–30 μL of RNase free water. The final yield should be 1–2 μg/μL.</li>
<li>Check the quality of RNA by standard RNA gel electrophoresis under denaturation conditions (<a href="#bib8">Rio, 2015</a>).</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> If the result of RNA electrophoresis shows a smear or multiple bands, redo the cRNA prep and be careful applying RNA handling techniques to avoid RNase contamination (<a href="#bib6">Nilsen, 2013</a>).</div>
<ol start="26">
<li>If no smearing is observed, make 2 μg RNA aliquots and store in −80°C freezer.</li>
</ol>
<h3 id="sec3.4">Electrical recordings using <i>Xenopus</i> oocytes—Defollicuating oocytes and injecting cRNA</h3>
<div class="timing">
<span class="timing-title">Timing:</span> 10 h totally over 4–6 days</div>
<p>The steps below describe the procedure to prepare <i>Xenopus</i> oocytes and to inject cRNA into these cells to induce uniporter expression for subsequent electrical recordings.</p>
<ol start="27">
<li>
<i>Xenopus laevis</i> ovary lobes can be purchased directly from Xenopus1. Alternatively, frogs can be housed in the institutional vivarium with ovary lobes obtained via laparotomy.</li>
<li>Rinse the ovary lobes three times with ND96. Fill a 50 mL conical tube with 20 mL of DB. Use scissors to cut the ovaries into lentil sized chunks into the tube, till the oocytes fill a volume of 5–10 mL.</li>
<li>Rinse oocytes with DB multiple times until the buffer runs clear.</li>
<li>Dissolve 12.5 mg of type II collagenase in 10 mL of DB. Use all this solution to digest oocytes at 25°C for 30 min. Discard the solution and rinse oocytes multiple times with fresh DB until the buffer runs clear.</li>
<li>Repeat step 30, 2–3 more times, until the follicle layer is fully digested (<a href="#fig2">Figure 2</a>).
<figure id="fig2"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1198-Fig2.jpg" alt="Fig2.jpg">
<figcaption>
<div class="figcaption-title">Figure 2. Images of oocytes</div>
<p>(A) Fully digested (left) vs incompletely digested oocytes (right).</p>
<p>(B) Unhealthy oocyte (left) vs healthy oocyte (right). Healthy oocytes are round, smooth, and have a clearly defined light hemisphere and dark hemisphere. The appearance of lighter spots (top arrow) or white colored lesions (bottom arrow) on the dark hemisphere suggests deteriorating health.</p>
<p>(C) Healthy oocyte (bottom) vs dying oocytes (top left and right). Dying oocytes lose the clear definition between the light and dark hemisphere (red arrow) and may begin to leak (blue arrow).</p>
</figcaption>
</figure>
</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> Check under a stereoscope to make sure that the follicle layer is mostly gone.</div>
<ol start="32">
<li>Rinse with DB till the solution is clear. Wash the oocytes 3–4 times with 20 mL of ND96. Transfer digested oocytes to multiple 10-cm tissue-culture dishes containing ND96 with &lt;100 oocytes/dish. Store the dishes at 17°C for 12–24 h before cRNA injection.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> Ensure that oocytes are completely submerged in ND96. Maintaining a low oocyte density (&lt;100 oocyte/dish) in 10-cm dishes is  to keep oocytes healthy.</div>
<ol start="33">
<li>Next day, select healthy stage V-VI oocytes, whose diameter should be ∼1 mm. Transfer them to new dishes with ND96.</li>
<li>Inject these oocytes with 30–60 ng of cRNA using a microinjector. 30–40 ng of cRNA is suitable for two-electrode voltage clamp, while 50–60 ng of cRNA is often necessary for patch clamp.</li>
<li>Transfer injected oocytes into 6-well plates (5 oocytes/well) filled with ND96. Change the buffer every day and remove dead oocytes.</li>
</ol>
<div class="critical">
<span class="critical-title">Critical:</span> It is important to remove dead oocytes (<a href="#fig2">Figure 2</a>) and remove buffers containing oocyte debris. In our hands, the presence of dead oocytes and the substances these cells release seem to make other oocytes sick.</div>
<ol start="36">
<li>The oocytes will be ready for two-electrode voltage clamp or patch-clamp 3–5 days after cRNA injection.</li>
</ol>
</section>
<section>
<h2 id="expected-outcomes">Expected outcomes</h2>
<h3 id="sec4.1">Mitochondrial <sup>45</sup>Ca<sup>2+</sup> uptake assay</h3>
<p>Below is the raw data from a typical mitochondrial <sup>45</sup>Ca<sup>2+</sup> uptake experiment using MICU1-knockout (KO) HEK293T cells (<a href="#bib7">Phillips et al., 2019</a>) in the presence of 300 nM free Ca<sup>2+</sup> (MICU1 is a regulatory subunit that blocks uniporter Ca<sup>2+</sup> transport in submicromolar Ca<sup>2+</sup> levels):</p>
<p>The uniporter-specific Ca<sup>2+</sup> uptake is then plotted against time (<a href="#fig3">Figure 3</a>) [Troubleshooting 1]. The data points are fitted with a linear equation to obtain the rate of uniporter-specific Ca<sup>2+</sup> uptake (nmol Ca<sup>2+</sup>/1 × 10<sup>6</sup> cells/min). Repeat this analysis in at least 3 independent replicates to obtain the average rate of uniporter-specific Ca<sup>2+</sup> uptake for data presentation. The example provided above (<a href="#tbl2">Table 2</a> and <a href="#fig3">Figure 3</a>) shows that MICU1-KO allows the uniporter to take up a significant amount of Ca<sup>2+</sup> in resting levels of cellular Ca<sup>2+</sup> as detailed in our previous work (<a href="#bib7">Phillips et al., 2019</a>; <a href="#bib13">Tsai et al., 2016</a>).</p>
<figure id="fig3"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1198-Fig3.jpg" alt="Fig3.jpg">
<figcaption>
<div class="figcaption-title">Figure 3. Uniporter-mediated mitochondrial <sup>45</sup>Ca<sup>2+</sup> uptake</div>
<p>Data points were fit with a linear equation (red line), yielding a rate of mitochondrial Ca<sup>2+</sup> uptake of 0.18 nmol/min/1 × 10<sup>6</sup> cells.</p>
</figcaption>
</figure>
<table id="tbl2">
<caption>Table 2. Data from a typical <sup>45</sup>Ca<sup>2+</sup> uptake experiment</caption>
<thead>
<tr>
<th> </th>
<th>Average signals from membranes, 2-min data point</th>
<th>Average signals from membranes, 4-min data point</th>
<th>Average signals from membranes, 6-min data point</th>
<th>Total signals in 100 μL solution</th>
</tr>
</thead>
<tbody>
<tr>
<td>Signals from tube A (no Ru360). Unit: cpm (count per minute)</td>
<td>14435</td>
<td>30545</td>
<td>46954</td>
<td>4545195</td>
</tr>
<tr>
<td>Tube B (+ Ru360)</td>
<td>2315</td>
<td>2481</td>
<td>2379</td>
<td>4607190</td>
</tr>
<tr>
<td>Uniporter-specific fractional uptake<sup><a href="#tblfn1">a</a></sup>
</td>
<td>2.7 × 10<sup>−3</sup>
</td>
<td>6.2 × 10<sup>−3</sup>
</td>
<td>9.8 × 10<sup>−3</sup>
</td>
<td> </td>
</tr>
<tr>
<td>Uniporter-specific Ca<sup>2+</sup> uptake<sup><a href="#tblfn2">b</a></sup>. Unit: nmol Ca<sup>2+</sup> /1 × 10<sup>6</sup> cells</td>
<td>0.27</td>
<td>0.62</td>
<td>0.98</td>
<td> </td>
</tr>
</tbody>
</table>
<p id="tblfn1" class="table-footnote"><sup>a</sup>Uniporter-specific fractional uptake = (Signals from membranes from tube A/total signals in 100 μL solution in tube A) – (Signals from membranes from tube B/total signals in 100 μL solution in tube B)</p>
<p id="tblfn2" class="table-footnote"><sup>b</sup>Uniporter-specific Ca<sup>2+</sup> uptake (nmol Ca<sup>2+</sup>/1 × 10<sup>6</sup> cells) = total calcium concentration in RB (after adding <sup>45</sup>Ca<sup>2+</sup>) ⨉ 100 μL ⨉ fractional uptake/5 × 10<sup>5</sup> cells</p>
<h3 id="sec4.2">Electrical recordings using <i>Xenopus</i> oocytes—Two-electrode voltage clamp</h3>
<p>We typically perform two-electrode voltage clamp using oocytes injected with 30–40 ng of hME cRNA for 3–4 days of expression. Oocytes are initially perfused in ND96 prior to the impalement of electrodes. Afterwards, currents are recorded in a Ca20 recording solution. Ca<sup>2+</sup> influx through the uniporter would induce outwardly rectifying, Ca<sup>2+</sup>-activated Cl<sup>-</sup> currents (CACC, <a href="#fig4">Figure 4</a>) [Troubleshooting 2]. Adding Ru360 inhibits the uniporter, thus causing a significant reduction of CACC (<a href="#fig4">Figure 4</a>). The amplitude of CACC can therefore be used to indirectly assess uniporter transport activity. To directly record uniporter-mediated Ca<sup>2+</sup> currents, one could inject 10 mM EGTA into oocytes before recording in Ca20 [Troubleshooting 3]. This maneuver will abolish CACC, thus revealing inwardly rectifying uniporter Ca<sup>2+</sup> currents (<a href="#bib12">Tsai and Tsai, 2018</a>; <a href="#bib14">Van Keuren et al., 2020</a>).</p>
<figure id="fig4"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1198-Fig4.jpg" alt="Fig4.jpg">
<figcaption>
<div class="figcaption-title">Figure 4. Two-electrode voltage clamp recordings of the uniporter in <i>Xenopus</i> oocytes</div>
<p>Adding Ru360 inhibits the uniporter, thus reducing the amplitude of the outwardly rectifying CACC.</p>
</figcaption>
</figure>
<h3 id="sec4.3">Electrical recordings using <i>Xenopus</i> oocytes—Patch clamp</h3>
<p>We normally perform patch-clamp recordings using the outside-out mode, with 10 mM EGTA in the pipet solution to eliminate CACC and 100 mM Ca<sup>2+</sup> in the perfusion solution (Ca100). Outside-out mode is used so that Ru360, which inhibits the uniporter from the intermembrane space, can be perfused to shut the uniporter during recordings. Oocytes injected with 50–60 ng of cRNA are allowed to express proteins for 3–5 days. The vitelline membrane of oocytes is removed right before the oocytes are placed in the recording chamber [Troubleshooting 4]. When using pipets with 3–4 MΩ pipet resistance, we can routinely obtain Ru360-inhibitable, macroscopic MCU Ca<sup>2+</sup> currents of &lt;5 pA (<a href="#fig5">Figure 5</a>) with the membrane potential clamped at −90 mV [Troubleshooting 5]. The single-channel amplitude of the uniporter is ∼0.25 pA under this recording condition, as also reported in mitoplast patch-clamp recordings (<a href="#bib5">Kirichok et al., 2004</a>).</p>
<figure id="fig5"><img src="https://prod-shared-star-protocols.s3.amazonaws.com/protocols/1198-Fig5.jpg" alt="Fig5.jpg">
<figcaption>
<div class="figcaption-title">Figure 5. Patch-clamp recordings of the uniporter in <i>Xenopus</i> oocyte membranes</div>
<p>(A) A representative single-channel recording.</p>
<p>(B) A representative macroscopic recording. Ru360 was shown to reversibly inhibit the uniporter.</p>
</figcaption>
</figure>
</section>
<section>
<h2 id="limitations">Limitations</h2>
<p>The main limitation for the mitochondrial <sup>45</sup>Ca<sup>2+</sup> uptake assay is the inability to control inner membrane potential, which is the driving force for Ca<sup>2+</sup> influx (<a href="#bib1">Bernardi, 1999</a>). It is possible that Ca<sup>2+</sup> influx could decrease the inner membrane potential, leading to gradually reduced driving force during the 6-min assay time course. However, we have shown elsewhere (<a href="#bib14">Van Keuren et al., 2020</a>) that this is not a concern as long as the researcher keeps Ca<sup>2+</sup> concentrations within the physiological range (&lt; 10 μM) when doing such experiments.</p>
<p>The membrane potential can be accurately clamped when doing electrical recordings of the uniporter in <i>Xenopus</i> oocyte membranes. The main limitation right now is that we only reconstituted the uniporter’s transmembrane subunits, MCU and EMRE, in the oocytes. We are actively working on establishing a procedure to also incorporate the regulatory MICU subunits (MICU1 and MICU2) to the system. However, recording with only the MCU and EMRE subunits will be adequate to study the most fundamental questions regarding the uniporter’s ion-conducting and Ca<sup>2+</sup>-selectivity mechanisms.</p>
</section>
<section>
<h2 id="troubleshooting">Troubleshooting</h2>
<h3 id="sec6.1">Problem 1</h3>
<p>Low signal-to-noise ratio in the mitochondrial <sup>45</sup>Ca<sup>2+</sup> uptake assay.</p>
<h3 id="sec6.2">Potential solution</h3>
<p>Make sure to use <sup>45</sup>Ca<sup>2+</sup> with enough specific activity. It’s imperative to use the <sup>45</sup>Ca<sup>2+</sup> stock within 6–8 months after delivery (the half-life of <sup>45</sup>Ca<sup>2+</sup> is ∼5 months). Incomplete block of the ER Ca<sup>2+</sup>-ATPase pump can also increase noise levels, so it’s important to replace the thapsigargin stock solution at least once per month. Finally, if the uniporter activity is from transiently expressed uniporter proteins, it is important to first confirm successful expression using Western blots.</p>
<h3 id="sec6.3">Problem 2</h3>
<p>Small currents in <i>Xenopus</i> oocyte two-electrode voltage clamp recordings.</p>
<h3 id="sec6.4">Potential solution</h3>
<p>In our hands, &lt;50% of <i>Xenopus</i> frogs produce useful oocytes for recordings. If the current is small, try another batch of oocytes from a different frog. It is also helpful to keep the oocytes in the best condition by maintaining a low cell density, removing dead cells, and changing media frequently.</p>
<h3 id="sec6.5">Problem 3</h3>
<p>Injecting EGTA into oocytes produces big leak currents in two-electrode voltage clamp.</p>
<h3 id="sec6.6">Potential solution</h3>
<p>We normally inject EGTA into oocytes and let the cells recover for at least 30 min before doing two-electrode voltage clamp. The wound caused by EGTA injection usually heals in this amount of time. However, this maneuver could produce big leak currents in sicker oocytes. If the leak issue becomes a big problem, we recommend setting up an injection electrode in the recording station. After the impalement of voltage and current electrodes, penetrate the oocyte with the injection electrode to inject EGTA and leave the electrode there for the entire recording.</p>
<h3 id="sec6.7">Problem 4</h3>
<p>Users encountering difficulties to remove the vitelline membrane.</p>
<h3 id="sec6.8">Potential solution</h3>
<p>Removing the oocyte vitelline membrane might be a challenge for inexperienced investigators. We find this video to be helpful to show new users how to execute this step. Oocytes become very fragile without the vitelline membrane, so it is very important to transfer the oocytes to recording chambers gently.</p>
<h3 id="sec6.9">Problem 5</h3>
<p>No uniporter currents in patch-clamp recordings with excised patches.</p>
<h3 id="sec6.10">Potential solution</h3>
<p>This is most likely due to low hME expression. One can increase the size of the pipet to have a resistance of 1–2 MΩ to increase the chance of capturing channels in excised patches. We also recommend the users to check hME expression by measuring whole-cell currents using two-electrode voltage clamp. Without at least 20–30 μA of CACC (120 mV), it would be very difficult to record currents in patch-clamp with 3–4 MΩ pipets.</p>
</section>
<section>
<h2 id="references">References</h2>
<p id="bib1">Bernardi, P. (1999). Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. <i>79</i>, 1127-1155. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00685-7/sref1">View at publisher</a></p>
<p id="bib2">Csordas, G., Golenar, T., Seifert, E.L., Kamer, K.J., Sancak, Y., Perocchi, F., Moffat, C., Weaver, D., Perez, S.F., Bogorad, R., et al. (2013). MICU1 controls both the threshold and cooperative activation of the mitochondrial Ca(2)(+) uniporter. Cell Metab <i>17</i>, 976-987. <a class="external-link" href="https://doi.org/10.1016/j.cmet.2013.04.020">https://doi.org/10.1016/j.cmet.2013.04.020</a></p>
<p id="bib3">Garg, V. and Kirichok, Y.Y. (2019). Patch-clamp analysis of the mitochondrial calcium uniporter. Methods Mol. Biol. <i>1925</i>, 75-86. <a class="external-link" href="https://doi.org/10.1007/978-1-4939-9018-4_7">https://doi.org/10.1007/978-1-4939-9018-4_7</a></p>
<p id="bib4">Kamer, K.J. and Mootha, V.K. (2015). The molecular era of the mitochondrial calcium uniporter. Nat. Rev. Mol. Cell Biol <i>16</i>, 545-553. <a class="external-link" href="https://doi.org/10.1038/nrm4039">https://doi.org/10.1038/nrm4039</a></p>
<p id="bib5">Kirichok, Y., Krapivinsky, G., and Clapham, D.E. (2004). The mitochondrial calcium uniporter is a highly selective ion channel. Nature <i>427</i>, 360-364. <a class="external-link" href="https://doi.org/10.1038/nature02246">https://doi.org/10.1038/nature02246</a></p>
<p id="bib6">Nilsen, T.W. (2013). The fundamentals of RNA purification. Cold Spring Harb Protoc. <i>2013</i>, 618-624. <a class="external-link" href="https://doi.org/10.1101/pdb.top075838">https://doi.org/10.1101/pdb.top075838</a></p>
<p id="bib7">Phillips, C.B., Tsai, C.W., and Tsai, M.F. (2019). The conserved aspartate ring of MCU mediates MICU1 binding and regulation in the mitochondrial calcium uniporter complex. Elife <i>8</i>. <a class="external-link" href="https://doi.org/10.7554/eLife.41112">https://doi.org/10.7554/eLife.41112</a></p>
<p id="bib8">Rio, D.C. (2015). Denaturation and electrophoresis of RNA with formaldehyde. Cold Spring Harb Protoc. <i>2015</i>, 219-222. <a class="external-link" href="https://doi.org/10.1101/pdb.prot080994">https://doi.org/10.1101/pdb.prot080994</a></p>
<p id="bib9">Rizzuto, R., De Stefani, D., Raffaello, A., and Mammucari, C. (2012). Mitochondria as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell Biol <i>13</i>, 566-578. <a class="external-link" href="https://doi.org/10.1038/nrm3412">https://doi.org/10.1038/nrm3412</a></p>
<p id="bib10">Rizzuto, R., Simpson, A.W., Brini, M., and Pozzan, T. (1992). Rapid changes of mitochondrial Ca2+ revealed by specifically targeted recombinant aequorin. Nature <i>358</i>, 325-327. <a class="external-link" href="https://doi.org/10.1038/358325a0">https://doi.org/10.1038/358325a0</a></p>
<p id="bib11">Sancak, Y., Markhard, A.L., Kitami, T., Kovacs-Bogdan, E., Kamer, K.J., Udeshi, N.D., Carr, S.A., Chaudhuri, D., Clapham, D.E., Li, A.A., et al. (2013). EMRE is an essential component of the mitochondrial calcium uniporter complex. Science <i>342</i>, 1379-1382. <a class="external-link" href="https://doi.org/10.1126/science.1242993">https://doi.org/10.1126/science.1242993</a></p>
<p id="bib12">Tsai, C.W. and Tsai, M.F. (2018). Electrical recordings of the mitochondrial calcium uniporter in Xenopus oocytes. J. Gen. Physiol. <i>150</i>, 1035-1043. <a class="external-link" href="https://doi.org/10.1085/jgp.201812015">https://doi.org/10.1085/jgp.201812015</a></p>
<p id="bib13">Tsai, M.F., Phillips, C.B., Ranaghan, M., Tsai, C.W., Wu, Y., Willliams, C., and Miller, C. (2016). Dual functions of a small regulatory subunit in the mitochondrial calcium uniporter complex. Elife <i>5</i>. <a class="external-link" href="https://doi.org/10.7554/eLife.15545">https://doi.org/10.7554/eLife.15545</a></p>
<p id="bib14">Van Keuren, A.M., Tsai, C.W., Balderas, E., Rodriguez, M.X., Chaudhuri, D., and Tsai, M.F. (2020). Mechanisms of EMRE-dependent MCU opening in the mitochondrial calcium uniporter complex. Cell Rep <i>33</i>, 108486. <a class="external-link" href="https://doi.org/10.1016/j.celrep.2020.108486">https://doi.org/10.1016/j.celrep.2020.108486</a></p>
<p id="bib15">Ying, W.L., Emerson, J., Clarke, M.J., and Sanadi, D.R. (1991). Inhibition of mitochondrial calcium ion transport by an oxo-bridged dinuclear ruthenium ammine complex. Biochemistry <i>30</i>, 4949-4952. <a class="external-link" href="http://refhub.elsevier.com/S2666-1667(21)00685-7/sref15">View at publisher</a></p>
</section>
<section>
<h2 id="article-info">Article info</h2>
<h3>Resource availability</h3>
<h4>Lead contact</h4>
<p>Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Ming-Feng Tsai, <a href="mailto:ming-feng.tsai@cuanschutz.edu">ming-feng.tsai@cuanschutz.edu</a></p>
<h4>Materials availability</h4>
<p>The hME <i>Xenopus</i> oocyte expression has been deposited into Addgene (#178181).</p>
<h4>Data and code availability</h4>
<p>The protocol did not generate datasets or codes.</p>
<h3>Acknowledgments</h3>
<p>M.X.R., A.M.V.K., and M.-F.T. are supported by the <a href="https://doi.org/10.13039/100000002">NIH</a> grant R01-GM129345. We thank Dr. Chen-Wei Tsai for critical reading of this manuscript.</p>
<h3>Author contributions</h3>
<p>All authors worked together to prepare figures, draft the protocol, and complete the final version.</p>
<h3>Declaration of interests</h3>
<p>The authors declare no competing interests.</p>
</section>
</article>